Published in Cancer Weekly, November 6th, 2001
"Decoy" technology involves using short DNA sequences to target proteins known as "transcription factors" that normally bind specific sequences in genomic DNA, thereby regulating downstream production of a protein. "Decoys" attach...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.